Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000450628

Medchemexpress LLC Ranolazine-d3 | 1054624-77-9 | 99.5% | 25 MG
SDP

Catalog No. 5000450628
Encompass_Preferred

Ranolazine-d3 is the deuterium labeled version of Ranolazine, an anti-angina agent that inhibits the late phase of inward sodium current (INa) and IKr, with IC50 values of 6 μM and 12 μM, respectively, without impacting heart rate or blood pressure. It also acts as a partial fatty acid oxidation (FAO) inhibitor. This compound is an antianginal agent primarily used for research purposes. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs.

  • Used as a tracer
  • Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS

Catalog No. 50-004-50628 Supplier Medchemexpress LLC Supplier No. 25MGHYB0280S2
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Ranolazine-d3 is the deuterium labeled version of Ranolazine, an anti-angina agent that inhibits the late phase of inward sodium current (INa) and IKr, with IC50 values of 6 μM and 12 μM, respectively, without impacting heart rate or blood pressure. It also acts as a partial fatty acid oxidation (FAO) inhibitor. This compound is an antianginal agent primarily used for research purposes. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs.

  • Used as a tracer
  • Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.